O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.71B
AUM Growth
-$772M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
149
New
Increased
Reduced
Closed

Top Buys

1
+$130M
2
+$104M
3
+$99.3M
4
BOLD
Audentes Therapeutics, Inc
BOLD
+$85.5M
5
EXEL icon
Exelixis
EXEL
+$79.4M

Top Sells

1
+$211M
2
+$155M
3
+$148M
4
BSX icon
Boston Scientific
BSX
+$141M
5
RLYP
RELYPSA INC COM
RLYP
+$137M

Sector Composition

1 Healthcare 93.45%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$17.5M 0.2%
462,325
+114,575
77
$16.8M 0.19%
114,000
78
$16.3M 0.19%
6,095,647
79
$16.1M 0.18%
+261,800
80
$15.9M 0.18%
+2,159,973
81
$15.7M 0.18%
2,667,500
82
$15.4M 0.18%
2,305,446
83
$14.4M 0.16%
+425,600
84
$14.2M 0.16%
1,276,190
85
$14M 0.16%
1,746,100
86
$13.5M 0.15%
116,600
87
$13.3M 0.15%
90,745
88
$13M 0.15%
58,000
+35,000
89
$12.6M 0.14%
+34,570
90
$12.4M 0.14%
3,802,000
91
$12M 0.14%
169,300
92
$11.5M 0.13%
757,365
93
$11M 0.13%
+3,072,196
94
$10.8M 0.12%
+235,400
95
$10.1M 0.11%
116,425
96
$9.38M 0.11%
337,500
-40,000
97
$9.27M 0.11%
5,260
98
$8.72M 0.1%
54,409
99
$8.43M 0.1%
350,000
100
$8.42M 0.1%
370,900
2 3
4
5 6